<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oman J Ophthalmol</journal-id><journal-id journal-id-type="iso-abbrev">Oman J Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">OJO</journal-id><journal-title-group><journal-title>Oman Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">0974-620X</issn><issn pub-type="epub">0974-7842</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29563712</article-id><article-id pub-id-type="pmc">5848365</article-id><article-id pub-id-type="publisher-id">OJO-11-97</article-id><article-id pub-id-type="doi">10.4103/0974-620X.226351</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Quiz</subject></subj-group></article-categories><title-group><article-title>A rare case of superior hypopyon with iris neovascularization</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mahajan</surname><given-names>Deepti</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Ravinder Kumar</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Chaudhary</surname><given-names>Kulbhushan Prakash</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><italic>Department of Ophthalmology, I.G.M.C., Shimla, Himachal Pradesh, India</italic></aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Deepti Mahajan, Arunodaya, Cemetery Road, Sanjauli, Shimla - 171 006 Himachal Pradesh, India. E-mail: <email xlink:href="mahajandeepti22@gmail.com">mahajandeepti22@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Apr</season><year>2018</year></pub-date><volume>11</volume><issue>1</issue><fpage>97</fpage><lpage>99</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2018 Oman Ophthalmic Society</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions></article-meta></front><body><p>A 70-year-old female presented to the eye outpatient department with the chief complaint of blurred vision, pain, and redness in the left eye for 2 days. Visual acuity in the right eye was 6/6 and hand movement close to face in the left eye. Slit lamp examination left eye revealed a superior hypopyon, +3 cells in the anterior chamber, and iris neovascularization [Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>]. Intraocular pressure by noncontact tonometer was 10 and 22 mm in the right and left eye, respectively. B-scan [<xref ref-type="fig" rid="F3">Figure 3</xref>] and magnetic resonance imaging (MRI) brain and orbit [<xref ref-type="fig" rid="F4">Figure 4</xref>] were ordered.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Superior mass, with neovascularization of the iris</p></caption><graphic xlink:href="OJO-11-97-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Post anterior chamber tap photograph showing hemorrhage superiorly and diffuse hyphema after the tap</p></caption><graphic xlink:href="OJO-11-97-g002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>B scan of the right and left eye revealing a mass in the ciliary region</p></caption><graphic xlink:href="OJO-11-97-g003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p>Magnetic resonance imaging brain and orbit</p></caption><graphic xlink:href="OJO-11-97-g004"/></fig><sec id="sec1-1"><title>Questions</title><p>
<list list-type="order"><list-item><p>What is the likely diagnosis?</p></list-item><list-item><p>What is the differential diagnosis?</p></list-item><list-item><p>What could be the cause of raised intraocular pressure in the left eye?</p></list-item><list-item><p>What are findings on ultrasound and MRI?</p></list-item><list-item><p>What is the line of management and workup for the patient?</p></list-item></list>
</p></sec><sec id="sec1-2"><title>Answers</title><p>
<list list-type="order"><list-item><p>Based on the clinical appearance and echographic findings, the patient was diagnosed ciliary body melanoma, with metastasis to the iris</p></list-item><list-item><p>Differential diagnosis are:</p><p>
<list list-type="bullet"><list-item><p>Posttraumatic fungal exudates</p></list-item><list-item><p>Metastasis</p></list-item><list-item><p>Lymphoma.</p></list-item></list>
</p></list-item><list-item><p>The mechanisms that can lead to glaucoma are the direct extension of the tumor into the trabecular meshwork, the seeding of tumor cells into outflow channels, pigment dispersion, inflammation, hemorrhage inducing hemolytic glaucoma, and melanomalytic glaucoma</p></list-item><list-item><p>B-scan revealed a mass in the ciliary region of the left eye [<xref ref-type="fig" rid="F3">Figure 3</xref>]. MRI brain with bilateral optic nerves was ordered which revealed altered signal intensity area in the ciliary body region, hyperintense on T2 and flair [<xref ref-type="fig" rid="F4">Figure 4</xref>]</p></list-item><list-item><p>Prednisolone Acetate 1% (G. Predforte) 4 times a day, Atropine 1% (G. Atro) three times a day, Timolol 0.5% and Brimonidine 0.2% (G. Brimocom) twice a day was given. A complete metastatic workup for tumor staging-complete blood count, basic metabolic panel, liver function tests (LFTs), chest X-ray, and abdominal ultrasound was done which were negative for evidence of metastasis. As it was an advanced and complicated tumor with metastasis to the iris, compromising the visual function, an elective enucleation surgery was planned. Size of the eyeball on gross examination was 2.5 cm &#x000d7; 2.5 cm &#x000d7; 1.3 cm. Outer surface of the eyeball was gray-white with prominent vascular markings [<xref ref-type="fig" rid="F5">Figure 5</xref>]. On cut section, posterior chamber showed a gray-brown growth attached on the scleral surface. Posterior half of the eyeball and optic nerve were not involved. Tumor in the choroid layer of the eyeball was seen on microscopic examination. Due to the clear margins and lack of evidence indicating distant metastasis, no further treatment was necessary and was counseled to undergo yearly eye exams with annual tumor surveillance, consisting of a physical examination, LFTs, and imaging of the liver with ultrasonography or MRI with contrast.</p></list-item></list>
</p><fig id="F5" position="float"><label>Figure 5</label><caption><p>Gross specimen of the eyeball of the size 2.5 cm &#x000d7; 2.5 cm &#x000d7; 1.3 cm with a gray-white growth attached on the scleral surface, with no involvement of the posterior half of the eyeball and optic nerve</p></caption><graphic xlink:href="OJO-11-97-g005"/></fig></sec><sec sec-type="discussion" id="sec1-3"><title>Discussion</title><p>Uveal melanoma is the most common primary intraocular malignancy in white adults. Melanoma of ciliary body is reported 1 of 10 cases of all intraocular melanomas.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>] Only two reports have been documented in India and none presented with glaucoma. This is a case from the Indian subcontinent of the primary ciliary body and choroidal melanoma presenting with secondary glaucoma and uveitis.</p><p>The most frequent symptoms are represented by local signs as blurry vision due to astigmatism or lens dislocations, floaters, painless visual field loss, or pain as a result of acute glaucoma.[<xref rid="ref1" ref-type="bibr">1</xref>]</p><p>Patient with iris involvement most commonly presents with a unilateral metastatic nodule.[<xref rid="ref3" ref-type="bibr">3</xref>] The liberation of friable cells often leads to a secondary iritis, episcleral injection, and occasionally, pseudohypopyon.[<xref rid="ref4" ref-type="bibr">4</xref>]</p><p>The ciliary body and anterior choroidal melanomas have the worst prognosis of all intraocular melanomas because (a) hematogenous metastasis is faster in ciliary body melanoma[<xref rid="ref1" ref-type="bibr">1</xref>] (b) late diagnosis of the tumor due to the absence of clinical signs in the early stages and anatomical localization, making it harder to identify.</p><p>External beam therapy or brachytherapy can be used for medium-sized tumor (&#x0003c;15 mm in diameter).[<xref rid="ref5" ref-type="bibr">5</xref>] In advanced cases, depending on the size, local extension and cellular type of the melanoma, the treatment is surgical, with enucleation of the eye, block excision, or sclerouvectomy consisting in an in-block removal of ciliary body, cornea, iris, and sclera following by grafting to close the defect.</p><sec id="sec2-1"><title>Declaration of patient consent</title><p>The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.</p></sec><sec id="sec2-2"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-3" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costache</surname><given-names>M</given-names></name><name><surname>Patrascu</surname><given-names>O</given-names></name><name><surname>Adrian</surname><given-names>D</given-names></name><name><surname>Costache</surname><given-names>D</given-names></name><name><surname>Sajin</surname><given-names>M</given-names></name><name><surname>Ungureanu</surname><given-names>E</given-names></name><name><surname>Simionescu</surname><given-names>O</given-names></name></person-group><article-title>Ciliary Body Melanoma - A Particularly Rare Type of Ocular Tumor.Case Report and General Considerations</article-title><source>Maedica</source><year>2013</year><volume>8</volume><fpage>360</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">24790669</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oittinen</surname><given-names>HA</given-names></name><name><surname>O'Shaughnessy</surname><given-names>M</given-names></name><name><surname>Cullinane</surname><given-names>AB</given-names></name><name><surname>Keohane</surname><given-names>C</given-names></name></person-group><article-title>Malignant melanoma of the ciliary body presenting as extraocular metastasis in the temporalis muscle</article-title><source>J Clin Pathol</source><year>2007</year><volume>60</volume><fpage>834</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17545559</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shields</surname><given-names>CL</given-names></name><name><surname>Shields</surname><given-names>JA</given-names></name><name><surname>Gross</surname><given-names>NE</given-names></name><name><surname>Schwartz</surname><given-names>GP</given-names></name><name><surname>Lally</surname><given-names>SE</given-names></name></person-group><article-title>Survey of 520 eyes with uveal metastases</article-title><source>Ophthalmology</source><year>1997</year><volume>104</volume><fpage>1265</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">9261313</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shields</surname><given-names>JA</given-names></name><name><surname>Shields</surname><given-names>CL</given-names></name><name><surname>Kiratli</surname><given-names>H</given-names></name><name><surname>de Potter</surname><given-names>P</given-names></name></person-group><article-title>Metastatic tumors to the iris in 40 patients</article-title><source>Am J Ophthalmol</source><year>1995</year><volume>119</volume><fpage>422</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">7709967</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demirci</surname><given-names>H</given-names></name><name><surname>Shields</surname><given-names>CL</given-names></name><name><surname>Shields</surname><given-names>JA</given-names></name><name><surname>Honavar</surname><given-names>SG</given-names></name><name><surname>Eagle</surname><given-names>RC</given-names><suffix>Jr</suffix></name></person-group><article-title>Ring melanoma of the ciliary body: Report on twenty-three patients</article-title><source>Retina</source><year>2002</year><volume>22</volume><fpage>698</fpage><lpage>706</lpage><pub-id pub-id-type="pmid">12476094</pub-id></element-citation></ref></ref-list></back></article>